A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer
Journal of Translational Medicine · 05.08.2024 · 22 (1)
DOI: 10.1186/s12967-024-05554-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Translational Medicine, online erschienen am 05.08.2024. Verfasst von Katia Grillone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. Hauptthemen laut MEDLINE: Neoplasms, Clinical Trials as Topic, RNA, Untranslated. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Targeting non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), has recently emerged as a promising strategy for treating malignancies and other diseases. In recent years, the development of ncRNA-based therapeutics for targeting protein-coding and non-coding genes has also gained momentum. This review systematically examines ongoing and completed clinical trials to provide a comprehensive overview of the emerging landscape of ncRNA-based therapeutics. Significant efforts have been made to advance ncRNA therapeutics to early clinical studies. The most advanced trials have been conducted with small interfering RNAs (siRNAs), miRNA replacement using nanovector-entrapped miRNA mimics, or miRNA silencing by antisense oligonucleotides. While siRNA-based therapeutics have already received FDA approval, miRNA mimics, inhibitors, and lncRNA-based therapeutics are still under evaluation in preclinical and early clinical studies. We critically discuss the rationale and methodologies of ncRNA targeting strategies to illustrate this rapidly evolving field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. tagliaferri@unicz.it.
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy. tassone@unicz.it.
ORCID-Profile: Pierfrancesco Tassone
Förderung
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Grillone, K., Caridà, G., Luciano, F., Cordua, A., Di Martino, M. T., Tagliaferri, P., & Tassone, P. (2024). A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05554-4
Vancouver
Grillone K, Caridà G, Luciano F, Cordua A, Di Martino MT, Tagliaferri P, et al. A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. Journal of Translational Medicine. 2024;22(1). doi:10.1186/s12967-024-05554-4
BibTeX
@article{Grillone2024,
author = {Grillone, Katia and Caridà, Giulio and Luciano, Francesco and Cordua, Alessia and Di Martino, Maria Teresa and Tagliaferri, Pierosandro and Tassone, Pierfrancesco},
title = {A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer},
journal = {Journal of Translational Medicine},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12967-024-05554-4}
}
EUVIMED